Literature DB >> 16449214

Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma.

Rossa W K Chiu1, Wing-bong Lui, Mei-chun Cheung, Nihal Kumta, Antonio Farina, Irina Banzola, Silvia Grotti, Nicola Rizzo, Christopher J Haines, Y M Dennis Lo.   

Abstract

BACKGROUND: Fetal RNA of placental origin has been detected in the plasma of pregnant women, but the timing of the first appearance and the detailed kinetics of postdelivery clearance of such circulating RNA have not been studied.
METHODS: To address the timing of the first appearance of circulating placental RNA, we collected serial maternal blood samples from 47 women who had conceived by assisted reproductive procedures. To address the postdelivery clearance kinetics, we collected serial postdelivery blood samples from 6 pregnant women who had delivered by cesarean section. Placenta-derived transcripts were sought by real-time quantitative reverse transcription-PCR.
RESULTS: The earliest gestational age at which human placental lactogen and human chorionic gonadotropin beta-subunit mRNAs were detectable in a proportion of the pregnant women was the 4th week of gestation. The postdelivery study indicated that the median apparent half-life for the clearance of human placental lactogen mRNA was 14 min.
CONCLUSIONS: Placenta-derived mRNA can be found in maternal plasma from very early on in gestation, suggesting a possible role for early noninvasive prenatal diagnosis or monitoring. The rapid kinetics of circulating placental mRNA suggest that its plasma concentrations may be used to monitor recent physiologic or pathologic events.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449214     DOI: 10.1373/clinchem.2005.059691

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

Review 1.  Cell-free fetal nucleic acids in amniotic fluid.

Authors:  L Hui; D W Bianchi
Journal:  Hum Reprod Update       Date:  2010-10-05       Impact factor: 15.610

Review 2.  From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges.

Authors:  Diana W Bianchi
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

3.  Integrative single-cell and cell-free plasma RNA transcriptomics elucidates placental cellular dynamics.

Authors:  Jason C H Tsang; Joaquim S L Vong; Lu Ji; Liona C Y Poon; Peiyong Jiang; Kathy O Lui; Yun-Bi Ni; Ka Fai To; Yvonne K Y Cheng; Rossa W K Chiu; Yuk Ming Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-22       Impact factor: 11.205

Review 4.  Tracking fetal development through molecular analysis of maternal biofluids.

Authors:  Andrea G Edlow; Diana W Bianchi
Journal:  Biochim Biophys Acta       Date:  2012-04-19

Review 5.  Single-Cell Immunobiology of the Maternal-Fetal Interface.

Authors:  Derek Miller; Valeria Garcia-Flores; Roberto Romero; Jose Galaz; Roger Pique-Regi; Nardhy Gomez-Lopez
Journal:  J Immunol       Date:  2022-10-15       Impact factor: 5.426

Review 6.  Nanostructures in non-invasive prenatal genetic screening.

Authors:  Samira Sadeghi; Mahdi Rahaie; Bita Ostad-Hasanzadeh
Journal:  Biomed Eng Lett       Date:  2021-10-11

7.  Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: The intersection of clinical, pathological, and high-dimensional biology studies.

Authors:  Nándor Gábor Than; Máté Posta; Dániel Györffy; László Orosz; Gergő Orosz; Simona W Rossi; Géza Ambrus-Aikelin; András Szilágyi; Sándor Nagy; Petronella Hupuczi; Olga Török; Adi L Tarca; Offer Erez; Zoltán Papp; Roberto Romero
Journal:  Placenta       Date:  2022-03-22       Impact factor: 3.287

8.  Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood.

Authors:  Jill L Maron; Kirby L Johnson; Donna Slonim; Chao-Qiang Lai; Marco Ramoni; Gil Alterovitz; Zina Jarrah; Zinger Yang; Diana W Bianchi
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  Identification of messenger RNA of fetoplacental source in maternal plasma of women with normal pregnancies and pregnancies with intrauterine growth restriction.

Authors:  Paola Ayala Ramírez; Reggie García Robles; Juan Diego Rojas; Martha Bermúdez; Jaime Bernal
Journal:  Colomb Med (Cali)       Date:  2012-09-30

10.  Non invasive prenatal diagnosis of aneuploidy: next generation sequencing or fetal DNA enrichment?

Authors:  A Webb; Te Madgett; T Miran; K Sillence; N Kaushik; M Kiernan; Nd Avent
Journal:  Balkan J Med Genet       Date:  2012-12       Impact factor: 0.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.